New Antitrust Risks from Introducing New Drugs
Update Magazine | November/December 2016
Interview Amy Rick Talks to Stephen Ubl, PhRMA
Update Magazine | November/December 2016
EU Agrees on New Medical Device and IVD Regulation
Update Magazine | November/December 2016
GLOBAL FOCUS: The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition GalleryGLOBAL FOCUS: The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition
Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update November/December 2016
GLOBAL FOCUS: The Approval and Substitutability of Biosimilars: Potential Impact on Use and Competition
Update Magazine | November/December 2016
Continuing the Discourse: FDA’s Public Hearing on Off-Label Communications
Update EXTRA | November 17, 2016
Social Media: Innovative Uses and Practical Experiences
Recorded November 17, 2016 | On-Demand Webinar
What’s Missing from MDUFA IV?
October 31, 2016 | Food and Drug Policy Forum
How Will FDA Regulate Off-Label Communications in the Post-Facteau World?
September 26, 2016 | Food and Drug Policy Forum
Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act GalleryTruth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 71.3
Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act
Food and Drug Law Journal | Volume 71 | Number 3
The Law of 180-Day Exclusivity (Open Access)
Food and Drug Law Journal | Volume 71 | Number 3
